S&P 500 Healthcare Sector SPDR (XLV)

Despite IQVIA’s underperformance compared to the healthcare sector over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.

Given Centene’s recent outperformance relative to its broader sector, analysts remain moderately optimistic about the stock’s prospects.

McKesson has significantly outpaced the broader healthcare sector over the past year, and analysts remain strongly bullish on the stock’s prospects.

Regeneron Pharmaceuticals has lagged behind the broader healthcare sector over the past year, still analysts are highly optimistic about the stock’s prospects.

Abbott Laboratories has outperformed the Health Care sector over the past year, and analysts are highly optimistic about the stock’s prospects.

Intuitive Surgical has outperformed its healthcare peers over the past year, and analysts remain moderately bullish about the stock's prospects.

UnitedHealth Group has notably underperformed its healthcare peers over the past year, yet analysts remain highly optimistic about the stock’s long-term prospects.

Johnson & Johnson has outpaced the broader healthcare sector over the past year, and analysts remain optimistic about the stock’s prospects.

West Pharmaceutical stock has notably lagged behind the broader market over the past year, yet analysts remain highly optimistic about the stock’s prospects.